Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...

Pharma stocks surge after US exempts products from tariffs, Nifty Pharma and healthcare indices show positive gains.

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

Indian pharmaceutical industry welcomes U.S. tariff exemption, boosting stock prices and reinforcing commitment to affordable, quality medicines.

While the Nifty IT index lost 4.21 per cent due to US recession fears, investors found comfort in the pharma sector, which ...

Indian equities brace for a roller coaster session on Thursday, April 3, as US President Donald Trump, in the early hours of ...

Our Bureau, New Delhi Thursday, April 3, 2025, 08:00 Hrs [IST] ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...

The exemption given to Indian pharmaceuticals is positive and, therefore, this segment is likely to witness buying, says ...